Forecast: Import of Extracts of Glands for Therapeutic Use to the US

The import data for extracts of glands for therapeutic use to the US shows a significant declining trend from 2024 to 2028. In 2023, the volume stood at a much higher level compared to the forecasted value for 2024, which is 18.93 thousand kilograms. By 2028, the forecast predicts a reduction to 1.48 thousand kilograms, indicating a sharp decrease in imports over the five-year period. This represents a compound annual growth rate (CAGR) decline, emphasizing a continuous decrease in demand or potential shifts in sourcing or production strategies for these extracts.

Future trends to watch for include potential policy changes in the US regarding the import of therapeutic substances, advancements in domestic production capabilities, and changes in global supply chain dynamics. Additionally, monitoring shifts in healthcare and pharmaceutical industry practices related to gland extracts will be crucial for understanding long-term import patterns.